Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Conference Call and Webcast To be Held Monday, December 28th, 2020 4:30 pm Eastern TimeNEW YORK, Dec. 22, 2020 (GLOBE...
Month: December 2020
Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Setmelanotide in Bardet-Biedl and Alström Syndromes
-- Study met primary endpoint and all key secondary endpoints with statistically significant and clinically meaningful reductions in weight and...
PolyPid Announces Positive Preclinical Data from OncoPLEX Intra-Tumoral Cancer Therapy Program
Single Local Treatment of OncoPLEX Showed Improved Overall Survival and Significantly Less Tumor Recurrence, and Reduced Systemic Toxicity Compared to...
Tonix Pharmaceuticals Acquires Exclusive License to University of Geneva Technology for Oxytocin-Based Treatments for Treating Insulin Resistance, Diabetes and Obesity, Expanding Proprietary Uses for TNX-1900 (Intranasal Potentiated Oxytocin)
University of Geneva Technology Covers Broad Applications for Cardiometabolic SyndromesCHATHAM, N.J., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding...
Allarity Therapeutics Draws Down the Third Tranche Under Its Convertible Note Agreement with Negma Group LTD and Park Partners GP
Press Release Hørsholm, Denmark (22 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that it...
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01
QuantuMDx diagnostic test for SARS-CoV-2 remains suitable for the detection of all discovered variants, including VUI-202012/01 NEWCASTLE UPON TYNE, UK,...
HEXO Corp Announces Lapse of Base Shelf Prospectus
OTTAWA, Dec. 22, 2020 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE:HEXO) announces that its amended...
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx(TM)
Study results are expected to support the Company's plans to file an IND application with the FDA for a Phase...
NextGen Healthcare, Inc. to Participate in the 39th Annual Virtual J.P. Morgan Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and...
Siemens Government Technologies Honored as a Top Technology Company in the Greater Washington Region by the Northern Virginia Technology Council
RESTON, Va.--(BUSINESS WIRE)--Siemens Government Technologies (SGT), Inc. – the federally-focused U.S. arm of technology powerhouse Siemens – is honored to...
Abivax to Present at the 39th Annual J.P. Morgan Healthcare Conference Ahead of Major Clinical Milestones
PARIS, FRANCE / ACCESSWIRE / December 21, 2020 / Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing...
DECN to Announce Various Testing Results This Week for Its COVID-19 GenViro! Swift Kit
The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test...
Peter A. Fields, MD, DC Shares Precautions His Clinic is Taking in Response to COVID-19
The OrthoRegen® Center for Regenerative Orthopedics is taking action to protect patients and staff during the pandemic SANTA MONICA, CA...
Medical Technology Company Heru, Inc. Completes FDA Registration Following a $2.7M Seed Round
Heru, Inc. comes out of stealth mode to announce the development of a novel artificial intelligence (AI) driven vision diagnostic...
Sweet Earth Products Featured in HEMP Magazine’s Holiday Gift Guide
Vancouver, British Columbia--(Newsfile Corp. - December 21, 2020) - Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) ("Sweet...
Update: Megola CEO Issues Letter to Shareholders
Anticipating an Exciting 2021 LAS VEGAS, NV / ACCESSWIRE / December 21, 2020 / Megola, Inc. (OTC PINK:MGON) (the "Company"),...
ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years
Supports Commercialization of TAEUSⓇ Product for Imaging NAFLD/NASH to December 2023 ANN ARBOR, MI / ACCESSWIRE / December 21, 2020...
Transradial Closure Devices Demand to Swell Due to Rising Cases of Cardiovascular Diseases: Future Market Insights
Major market players are engaged in launching compact, ultra-modern devices with the purpose of targeting diverse end users. DUBAI, UAE...
9 Meters Biopharma Announces Agreement with the European Biomedical Research Institute of Salerno (EBRIS) to Continue Evaluation of Larazotide for COVID-19 Respiratory Complications
Larazotide, a novel tight junction modulator, has shown positive effect in multiple lung models of acute respiratory distress, acute lung...